Press release
WALTHAM, Massachusetts — PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced that the Company has completed its previously announced acquisition of EUROIMMUN Medical Laboratory Diagnostics AG. PerkinElmer originally announced its intent to acquire EUROIMMUN on June 19, 2017.
https://www.businesswire.com/news/home/20171219006118/en/PerkinElmer-Completes-Acquisition-EUROIMMUN
